Related references
Note: Only part of the references are listed.Chemopreventive strategies in hepatocellular carcinoma
Siddharth Singh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Statins and primary liver cancer: a meta-analysis of observational studies
Danitza Pradelli et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Statin use and risk of hepatocellular carcinoma
Shih-Wei Lai et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2013)
Common cancer risk and statins: a population-based case-control study in a Chinese population
Henry W. C. Leung et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Statins and Cancer in Gastroenterology: New Insight?
Patrizia Gazzerro et al.
GASTROENTEROLOGY (2013)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk
Roongruedee Chaiteerakij et al.
HEPATOLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates
Naomi Gronich et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Statin use and risk of liver cancer: A meta-analysis of 7 studies involving more than 4.7 million patients
Hui Zhang et al.
WORLD JOURNAL OF META-ANALYSIS (2013)
Statin use and risk of breast cancer: a meta-analysis of observational studies
Krishna Undela et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Statin use and risk of pancreatic cancer: a meta-analysis
Xiaobing Cui et al.
CANCER CAUSES & CONTROL (2012)
Clinical Perspective: Statins and the Liver-Harmful or Helpful?
James H. Lewis
DIGESTIVE DISEASES AND SCIENCES (2012)
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Chun-Ying Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: A comprehensive review
Simon Zeichner et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2012)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Potential for statins in the chemoprevention and management of hepatocellular carcinoma
Amedeo Lonardo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Jonathan R. Emberson et al.
PLOS ONE (2012)
Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Dipika Bansal et al.
PLOS ONE (2012)
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Patrizia Gazzerro et al.
PHARMACOLOGICAL REVIEWS (2012)
Statin Use and the Risk of Liver Cancer: A Population-Based Case-Control Study
Hui-Fen Chiu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers
Shouji Shimoyama
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line
M. P. Polo et al.
CELL BIOCHEMISTRY AND FUNCTION (2011)
Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea
Cari M. Kitahara et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Statins and Risk of Cancer A Retrospective Cohort Analysis of 45,857 Matched Pairs From an Electronic Medical Records Database of 11 Million Adult Americans
Claudio Marelli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Myth of Statin-Induced Hepatotoxicity
Ted Bader
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Statin use and cancer risk: a comprehensive review
Denise M. Boudreau et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Effect of statin therapy on colorectal cancer
Marc Bardou et al.
GUT (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
Yasuyuki Matsushita et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma
Won Kim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer
Jiyoung Ahn et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Serum cholesterol levels in relation to the incidence of cancer: The JPHC study cohorts
Hiroyasu Iso et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis A Randomized Placebo-controlled Trial
Austin Nelson et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Chemoembolization Combined with Pravastatin Improves Survival in Patients with Hepatocellular Carcinoma
Hannah Graf et al.
DIGESTION (2008)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients
Gary D. Friedman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, Multicenter trial
James H. Lewis et al.
HEPATOLOGY (2007)
Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Statins and risk of cancer: A systematic review and metaanalysis
Danielle R. L. Browning et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Fluvastatin treatment is not associated with an increased incidence of cancer
E. A. Stein et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Statins and cancer risk - A meta-analysis
KM Dale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Cancer risk among statin users: A population-based cohort study
S Friis et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Statistics Notes - Interaction revisited: the difference between two estimates
DG Altman et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
S Kawata et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
